Get the Stockscreener App
2.04
3.32%
-0.07
After Hours:
2.08
0.04
+1.96%
BioStem Technologies, Inc. Common Stock Stock (BSEM) Forecast
The BioStem Technologies, Inc. Common Stock (BSEM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.7865, representing a +36.59% increase from the current price of $2.04. The highest analyst price target is $3.3615, and the lowest is $2.2115.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BSEM Price Target
Average 3.1388
(+53.86% Upside)
Is BioStem Technologies, Inc. Common Stock (BSEM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.48 | Buy |
| STOCH(9,6) | 9.103 | Buy |
| STOCHRSI(14) | 4.9642 | Buy |
| MACD(12,26) | -0.4539 | Sell |
| ADX(14) | 25.86 | Sell |
| William %R | -93.45 | Buy |
| CCI(14) | -59.19 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.4295
Sell
|
2.5014
Sell
|
| MA20 |
3.1638
Sell
|
2.9061
Sell
|
| MA50 |
3.5154
Sell
|
3.3525
Sell
|
| MA100 |
3.6053
Sell
|
3.6905
Sell
|
| MA200 |
4.3559
Sell
|
4.4743
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BSEM could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on BSEM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.48 indicates that BSEM is oversold. This indicates that BSEM price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 9.103 indicates that BSEM is oversold. This indicates that BSEM price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.9642 indicates that BSEM is oversold. This suggests that BSEM price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.86 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -59.19 indicates that BSEM is still oversold but not to an extreme extent.
Long-term BSEM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about BioStem Technologies, Inc. Common Stock financial reports and earnings history, BioStem Technologies, Inc. Common Stock (BSEM) stock could reach $13.41 by 2030, $9.6632 by 2040 and $6.8106 by 2050. See the projected annual prices until 2050 of the BioStem Technologies, Inc. Common Stock stock below:
- BioStem Technologies, Inc. Common Stock (BSEM) is expected to reach an average price of $5.6031 in 2035, with a high prediction of $6.3331 and a low estimate of $4.8974. This indicates an $174.66% rise from the last recorded price of $2.04.
- BioStem Technologies, Inc. Common Stock (BSEM) stock is projected to chart a bullish course in 2040, with an average price target of $7.5041, representing an $267.85% surge from its current level. The forecast ranges from a conservative $5.0123 to a sky-high $9.6632.
- Our analysts predict BioStem Technologies, Inc. Common Stock (BSEM) to jump 195.33% by 2045, soaring from $5.7048 to an average price of $6.0248, potentially reaching $6.9548. While $5.7048 is the low estimate, the potential upside is significant.
- BioStem Technologies, Inc. Common Stock (BSEM) stock is expected to climb by 2050, reaching an average of $5.6852, a $178.68% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.8106 and $4.4031, respectively, highlighting the market's uncertainty.
BioStem Technologies, Inc. Common Stock Stock (BSEM) Year by Year Forecast
BioStem Technologies, Inc. Common Stock Stock (BSEM) Price Forecast for 2026
The predicted value for BioStem Technologies, Inc. Common Stock (BSEM) in 2026 is set at an average of $5.25. Estimates vary from a peak of $8.40 to a trough of $2.10, indicating an +157.35% surge from the present price of $2.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $3.3518 | $2.2115 | $3.3615 | +64.30% |
| December, 2026 | $4.163 | $2.2224 | $4.7027 | +104.07% |
BioStem Technologies, Inc. Common Stock Stock (BSEM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for BioStem Technologies, Inc. Common Stock (BSEM) is $2.92, with a high forecast of $4.2651 and a low forecast of $1.5748. This indicates an +43.14% increase from the last price of $2.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.9142 | $2.6139 | $4.1633 | +91.87% |
| February, 2027 | $3.6104 | $2.8654 | $4.2651 | +76.98% |
| March, 2027 | $3.847 | $2.8663 | $3.9163 | +88.58% |
| April, 2027 | $3.1682 | $2.8673 | $3.3773 | +55.30% |
| May, 2027 | $3.8697 | $3.0385 | $4.0697 | +89.69% |
| June, 2027 | $3.0209 | $2.6209 | $3.87 | +48.08% |
| July, 2027 | $3.5721 | $2.1712 | $3.8718 | +75.10% |
| August, 2027 | $2.3736 | $2.3136 | $3.6724 | +16.35% |
| September, 2027 | $2.3748 | $1.5748 | $2.4239 | +16.41% |
| October, 2027 | $1.996 | $1.5754 | $2.3757 | -2.16% |
| November, 2027 | $1.815 | $1.5875 | $3.0075 | -11.03% |
| December, 2027 | $2.1287 | $1.8478 | $2.3787 | +4.35% |
BioStem Technologies, Inc. Common Stock Stock (BSEM) Price Forecast for 2028
In 2028, BioStem Technologies, Inc. Common Stock (BSEM) is projected to reach an average price of $8.879, with a high projection of $15.89 and a low estimate of $1.869. This indicates an +335.25% rise from the last price of $2.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.7555 | $1.869 | $3.8803 | +84.09% |
| February, 2028 | $3.5415 | $2.6509 | $4.1812 | +73.60% |
| March, 2028 | $4.0127 | $2.6418 | $4.1227 | +96.70% |
| April, 2028 | $6.4839 | $3.8133 | $6.8839 | +217.84% |
| May, 2028 | $5.6354 | $5.1554 | $7.3842 | +176.24% |
| June, 2028 | $9.6266 | $4.7957 | $10.99 | +371.89% |
| July, 2028 | $10.01 | $8.6372 | $10.25 | +390.59% |
| August, 2028 | $13.04 | $9.6884 | $15.89 | +539.18% |
| September, 2028 | $8.3905 | $8.3505 | $13.19 | +311.30% |
| October, 2028 | $7.782 | $7.3917 | $10.44 | +281.47% |
| November, 2028 | $9.8833 | $7.1626 | $10.24 | +384.47% |
| December, 2028 | $9.1745 | $8.4442 | $11.81 | +349.73% |
BioStem Technologies, Inc. Common Stock Stock (BSEM) Price Forecast for 2029
The 2029 price forecast for BioStem Technologies, Inc. Common Stock Stock (BSEM) is $18.01 on average, with a high prediction of $28.66 and a low estimate of $7.3566. This represents an +782.67% increase from the previous price of $2.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.42 | $8.0951 | $14.72 | +459.61% |
| February, 2029 | $10.40 | $9.7966 | $11.40 | +409.67% |
| March, 2029 | $12.35 | $10.01 | $14.28 | +505.31% |
| April, 2029 | $14.30 | $10.97 | $28.66 | +600.98% |
| May, 2029 | $17.61 | $11.79 | $18.34 | +763.41% |
| June, 2029 | $14.38 | $12.20 | $18.34 | +605.04% |
| July, 2029 | $19.00 | $12.91 | $19.68 | +831.56% |
| August, 2029 | $12.58 | $12.49 | $19.00 | +516.42% |
| September, 2029 | $9.0062 | $8.7762 | $12.89 | +341.48% |
| October, 2029 | $14.53 | $7.3566 | $16.15 | +612.15% |
| November, 2029 | $12.38 | $10.82 | $15.86 | +507.06% |
| December, 2029 | $13.91 | $10.41 | $14.93 | +581.89% |
BioStem Technologies, Inc. Common Stock Stock (BSEM) Price Forecast for 2030
BioStem Technologies, Inc. Common Stock Stock (BSEM) is expected to reach an average price of $8.4609 in 2030, with a high forecast of $13.41 and a low forecast of $3.5109. This signifies an +314.75% surge from the last price of $2.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.66 | $9.9617 | $13.41 | +471.65% |
| February, 2030 | $10.76 | $10.41 | $12.41 | +427.59% |
| March, 2030 | $7.1141 | $5.4332 | $11.12 | +248.73% |
| April, 2030 | $5.3726 | $4.9153 | $6.9644 | +163.36% |
| May, 2030 | $5.2617 | $4.4812 | $5.9165 | +157.93% |
| June, 2030 | $5.278 | $3.5109 | $5.398 | +158.73% |
| July, 2030 | $4.2295 | $3.9789 | $5.3683 | +107.33% |
| August, 2030 | $7.5708 | $4.0199 | $7.6208 | +271.12% |
| September, 2030 | $6.0598 | $5.4714 | $8.8211 | +197.05% |
| October, 2030 | $4.8488 | $4.6335 | $6.5126 | +137.69% |
| November, 2030 | $5.3947 | $4.4238 | $6.5144 | +164.45% |
| December, 2030 | $4.7462 | $4.4262 | $5.6762 | +132.66% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):